Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2024 Filed Sep 4, 2024 22:26 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 100 | $25.37 | $2,537.00 |
DisclosureSEC source: 0001714899-24-000198 · wk-form4_1725483889.xml · nonDerivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,176 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F3 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 22:26 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 2,980 | $24.99 | $74,470.20 |
DisclosureSEC source: 0001714899-24-000198 · wk-form4_1725483889.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,276 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.37 to $25.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:14 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,547 | $24.78 | $63,114.66 |
DisclosureSEC source: 0001714899-24-000195 · wk-form4_1724357674.xml · nonDerivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,066 F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.19 to $25.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:14 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 5,907 | $24.96 | $147,438.72 |
DisclosureSEC source: 0001714899-24-000194 · wk-form4_1724357642.xml · nonDerivative · entry 3 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,810 F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023. F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.84 to $25.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:14 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 14,098 | $24.41 | $344,132.18 |
DisclosureSEC source: 0001714899-24-000194 · wk-form4_1724357642.xml · nonDerivative · entry 2 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,717 F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.84 to $24.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:16 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 2,260 | $23.79 | $53,765.40 |
DisclosureSEC source: 0001714899-24-000197 · wk-form4_1724357777.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,807 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · balance_after: Includes 197,200 Unvested RSUs. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:14 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 3,353 | $23.54 | $78,929.62 |
DisclosureSEC source: 0001714899-24-000195 · wk-form4_1724357674.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,613 F3 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.38 to $23.72 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:14 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,453 | $23.79 | $58,356.87 |
DisclosureSEC source: 0001714899-24-000195 · wk-form4_1724357674.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,966 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:15 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 1,727 | $23.79 | $41,085.33 |
DisclosureSEC source: 0001714899-24-000196 · wk-form4_1724357741.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,677 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.75 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 13,467 Unvested RSUs. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:14 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,453 | $23.79 | $58,356.87 |
DisclosureSEC source: 0001714899-24-000194 · wk-form4_1724357642.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,815 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.62 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 118,810 Unvested RSUs. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 20:10 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,272 | $22.89 | $52,006.08 |
DisclosureSEC source: 0001714899-24-000177 · wk-form4_1723752595.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,419 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · balance_after: Includes 123,810 RSUs. F3 · balance_after: Includes 1,350 shares acquired under the ESPP Purchase on May 31, 2024. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 20:09 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,337 | $22.89 | $53,493.93 |
DisclosureSEC source: 0001714899-24-000176 · wk-form4_1723752552.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,268 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · balance_after: Includes 123,810 RSUs. Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 01:13 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 100 | $22.80 | $2,280.00 |
DisclosureSEC source: 0001714899-24-000156 · wk-form4_1720055619.xml · nonDerivative · entry 3 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,404 F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023. F1 · balance_after: Includes 18,467 unvested RSUs. Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 01:13 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 29,900 | $22.12 | $661,388.00 |
DisclosureSEC source: 0001714899-24-000156 · wk-form4_1720055619.xml · nonDerivative · entry 2 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,504 F2 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023. F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $21.80 to $22.78 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 18,467 unvested RSUs. F4 · balance_after: Reflects an allocation of 11,784 shares from the Steven Edward Krognes Revocable Trust to the Reporting Person. Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 01:13 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 100 | $22.86 | $2,286.00 |
DisclosureSEC source: 0001714899-24-000155 · wk-form4_1720055578.xml · nonDerivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,256 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F3 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 01:13 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 2,980 | $22.12 | $65,917.60 |
DisclosureSEC source: 0001714899-24-000155 · wk-form4_1720055578.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,356 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $21.86 to $22.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| June 13, 2024 Filed Jul 4, 2024 01:13 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 688 | $21.79 | $14,991.52 |
DisclosureSEC source: 0001714899-24-000156 · wk-form4_1720055619.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,620 F1 · balance_after: Includes 18,467 unvested RSUs. Read SEC document |
| June 06, 2024 Filed Jun 11, 2024 00:06 UTC |
Cook Jennifer E.Director
|
SaleCommon Stock | 1,458 | $21.73 | $31,682.34 |
DisclosureSEC source: 0001714899-24-000145 · wk-form4_1718064363.xml · nonDerivative · entry 1 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,038 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 7, 2024. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:33 UTC |
Krognes Steve E.Director
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000142 · wk-form4_1717540391.xml · derivative · entry 3 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:33 UTC |
Krognes Steve E.Director
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000142 · wk-form4_1717540391.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,308 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 18,467 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:32 UTC |
Thornberry NancyDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000141 · wk-form4_1717540348.xml · derivative · entry 2 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:32 UTC |
Thornberry NancyDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000141 · wk-form4_1717540348.xml · nonDerivative · entry 1 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,680 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6595 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:31 UTC |
Tessier-Lavigne MarcDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000140 · wk-form4_1717540308.xml · derivative · entry 5 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F6 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:31 UTC |
Tessier-Lavigne MarcDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000140 · wk-form4_1717540308.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,880,539 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:30 UTC |
SATO VICKI LDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000138 · wk-form4_1717540239.xml · derivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:30 UTC |
SATO VICKI LDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000138 · wk-form4_1717540239.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,336 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:30 UTC |
Cook Jennifer E.Director
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000137 · wk-form4_1717540199.xml · derivative · entry 2 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:30 UTC |
Cook Jennifer E.Director
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000137 · wk-form4_1717540199.xml · nonDerivative · entry 1 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,496 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:29 UTC |
Schenkein David PDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000136 · wk-form4_1717540157.xml · derivative · entry 4 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:29 UTC |
Schenkein David PDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000136 · wk-form4_1717540157.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,496 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:28 UTC |
FLATLEY JAY TDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000135 · wk-form4_1717540113.xml · derivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:28 UTC |
FLATLEY JAY TDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000135 · wk-form4_1717540113.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,183 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. F3 · balance_after: Includes shares previously reported as held by The Flatley Family Trust. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:27 UTC |
Harris ErikDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000134 · wk-form4_1717540070.xml · derivative · entry 2 Harris Erik · CIK 0001780113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:27 UTC |
Harris ErikDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000134 · wk-form4_1717540070.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,052 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 9,402 unvested RSUs. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:20 UTC |
Klein Peter SDirector
|
GrantStock Option (right to buy) · Derivative | 17,901 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0001714899-24-000133 · wk-form4_1717539614.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:20 UTC |
Klein Peter SDirector
|
GrantCommon Stock | 5,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000133 · wk-form4_1717539614.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,496 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:28 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,674 | $20.39 | $34,132.86 |
DisclosureSEC source: 0001714899-24-000122 · wk-form4_1715977693.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,369 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 27, 2023. F2 · balance_after: Includes 4,216 unvested RSUs. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 21:14 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $18.29 | $30,471.14 |
DisclosureSEC source: 0001714899-24-000104 · wk-form4_1713388471.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,043 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 27, 2023. F2 · balance_after: Includes 4,216 unvested RSUs. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:07 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 92,500 | $20.50 | $1,896,250.00 |
DisclosureSEC source: 0001714899-24-000098 · wk-form4_1712095651.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,341 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 1, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $20.06 to $20.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 16,716 unvested RSUs. Read SEC document |
| March 29, 2024 Filed Mar 29, 2024 21:59 UTC |
Watts Ryan J.Director · President and CEO
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-24-000097 · wk-form4_1711749539.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,202,604 F1 · shares: Reflects an in-kind charitable contribution of 40,000 shares of DNLI to a donor advised fund. F2 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:27 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $20.10 | $33,486.60 |
DisclosureSEC source: 0001714899-24-000092 · wk-form4_1710880039.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,709 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.72 to $20.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 4,216 unvested RSUs. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:38 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 1,666 | $18.37 | $30,604.42 |
DisclosureSEC source: 0001714899-24-000066 · wk-form4_1708468690.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,375 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $18.24 to $18.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 4,216 RSUs. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 02:14 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 20,128 | $17.66 | $355,460.48 |
DisclosureSEC source: 0001714899-24-000059 · wk-form4_1708049627.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,341 F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 129,435 RSUs. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 02:14 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 1,405 | $17.79 | $24,994.95 |
DisclosureSEC source: 0001714899-24-000060 · wk-form4_1708049673.xml · nonDerivative · entry 2 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,605 F4 · kind: The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.55 to $17.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price F3 · balance_after: Includes 129,435 RSUs. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 02:15 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 9,589 | $17.29 | $165,793.81 |
DisclosureSEC source: 0001714899-24-000061 · wk-form4_1708049710.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,067 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price F3 · balance_after: Includes 202,200 RSUs. F4 · balance_after: Reflects 25,759 shares previously disclosed as held indirectly; but have been determined to be held directly. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 02:14 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,716 | $17.29 | $46,959.64 |
DisclosureSEC source: 0001714899-24-000059 · wk-form4_1708049627.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,469 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 129,435 RSUs. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 02:16 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 2,750 | $17.29 | $47,547.50 |
DisclosureSEC source: 0001714899-24-000062 · wk-form4_1708049752.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,841 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.07 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 16,716 RSUs. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 02:14 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,784 | $17.29 | $48,135.36 |
DisclosureSEC source: 0001714899-24-000060 · wk-form4_1708049673.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,010 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 129,435 RSUs. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:48 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-24-000042 · wk-form4_1707774481.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,078 Underlying: Common Stock · 50,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:48 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionCommon Stock | 50,000 | $0.68 | $34,000.00 |
DisclosureSEC source: 0001714899-24-000042 · wk-form4_1707774481.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 136,721 RSUs. F2 · balance_after: Reflects 15,558 shares previously disclosed as held indirectly; but have been determined to be held directly. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.